Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-15

Clinical Trial Update: A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of Permethrin Foam 5% and 4% for scabies has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Permethrin Foam 4% (permethrin)
  • Permethrin Foam 5% (permethrin)

Snippet

Sponsor: Mylan Inc. | Conditions: Scabies | Phase 2 | Status: COMPLETED | Results posted: 2021-01-15